Maternal serum screening for Down syndrome: Are women's perceptions changing?

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 114, Issue 4, 2007, Pages 458-461

  Gidiri, M ^a   McFarlane, J ^b   Holding, S ^a   Lindow, S W ^a  

^a HULL ROYAL INFIRMARY   (United Kingdom)

^b CASTLE HILL HOSPITAL   (United Kingdom)

Author keywords

Down's syndrome; Epidemiology; Pregnancy; Screening uptake; Serum screening

Indexed keywords

DOWN SYNDROME; HUMAN; INFORMATION RETRIEVAL; MATERNAL SERUM; MEDICAL DOCUMENTATION; PREGNANT WOMAN; PRENATAL CARE; PRIORITY JOURNAL; REFERENCE DATABASE; RETROSPECTIVE STUDY; REVIEW; SAMPLE SIZE; SCREENING TEST; UNITED KINGDOM;

ADULT; ATTITUDE TO HEALTH; DOWN SYNDROME; FEMALE; HUMANS; MATERNAL AGE; PATIENT ACCEPTANCE OF HEALTH CARE; PERCEPTION; PREGNANCY; PRENATAL DIAGNOSIS; RETROSPECTIVE STUDIES;

EID: 33847780298     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2007.01266.x     Document Type: Review

References (12)

1. Cuckle HS, Wald NJ, Lindenbaum RH. Maternal serum alpha-fetoprotein measurement: a screening test for Down's syndrome. Lancet 1984;1:926-9.
2. Canick JA, Knight GJ, Palomaki GE, Haddow JE, Cuckle HS, Wald NJ. Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome. Br J Obstet Gynaecol 1988;95:330-3.
3. Wald NJ, Cuckle HS, Densem JW, Nanchahal K, Canick JA, Haddow JE, et al. Maternal serum unconjugated oestriol as an antenatal screening test for Down's syndrome. Br J Obstet Gynaecol 1988;95:334-41.
4. Wald NJ, Kennard A, Densem JW, Cuckle HS, Chard T, Butler L. Antenatal maternal serum screening for Down's syndrome: results of a demonstration project. BMJ 1992;305:391-4.
5. Department of Health. Model of Best Practice for Providing Screening Services. 2003. [www.screening.nhs.uk/downs/model_bestpractice.pdf]. Accessed 19 December 2006.
6. Wald NJ, Rodeck C, Hackshaw AK, Walters J, Chitty L, Mackinson AM. First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). Health Technol Assess 2003;7:1-77.
7. Spencer K, Spencer CE, Power M, Moakes A, Nicolaides KH. One stop clinic for assessment of risk for fetal anomalies: a report of the first year of prospective screening for chromosomal anomalies in the first trimester. BJOG 2000;107:1271-5.
8. Salonen R, Turpeinen U, Kurki L, Lappalainen M, Ammala P, Hiilesmaa V, et al. Maternal serum screening for Down's syndrome on population basis. Acta Obstet Gynecol Scand 1997;76:817-21.
9. Goldie DJ, Astley JP, Beaman JM, Bickley DA, Gunneberg A, Jones SR. Screening for Down's syndrome: the first two years experience in Bristol. J Med Screen 1995;2:207-10.
10. Dormandy E, Michie S, Hooper R, Marteau TM. Low uptake of prenatal screening for Down's syndrome in minority ethnic groups and socially deprived groups: a reflection of women's attitudes or failure to facilitate informed choice. Int J Epidemiol 2005;34:346-52.
11. Ford C, Moore AJ, Jordan PA, Bartlett WA, Wyldes MP, Jones AF, et al. The value of screening for Down's syndrome in a socioeconomically deprived area with a high ethnic population. Br J Obstet Gynaecol 1998;105:855-9.
12. 2001 Census. Kingston upon Hull. Ethnicity and religion. 2001 [www.statistics.gov.uk/census2001/profiles/00FA-A.asp]. Accessed 19 December 2006.